Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
The present study evaluated the role of various neurotransmitter systems in mediating buspirone's blockade of the fear-potentiated startle effect, where acoustic startle amplitude is normally increase in the presence of a light previously paired with a shock. Large lesions of the dorsal and median raphe nuclei or IP injections of the serotonin antagonists cinanserin (10 mg/kg) or cyproheptadine (5 mg/kg) did not alter fear-potentiated startle, nor did these treatments prevent buspirone (5 or 10 mg/kg SC) from blocking fear-potentiated startle. The 5-HT 1A agonist 8-OH-DPAT (2.5-10.0) did not block fear-potentiated startle even at doses that produced a marked "5-HT syndrome". Another 5-HT 1A agonist, ipsapirone (10-20 mg/kg), blocked potentiated startle only at a very high dose (40 mg/kg). p-Chlorophenylalanine and p-chloroamphetamine did not alter fear-potentiated startle. Finally, pretreatment with the benzodiazepine receptor antagonist RO-15-1788 (1 mg/kg); the opiate antagonist naloxone (2 mg/kg) or the alpha 2-adrenergic antagonist yohimbine (5 mg/kg) did not reduce fear-potentiated startle, nor did they prevent buspirone from blocking fear-potentiated startle. Taken together, the data do not support the hypothesis that buspirone's anxiolytic effects are mediated by actions at 5-HT 1A receptors and more generally indicate that serotonergic neurons do not play an important role in fear-potentiated startle.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is in line with the clinical observation that specific phobias respond less well to treatments such as citalopram than other pathological anxiety states (Baldwin et al, 2005) and with preclinical evidence in rodents showing that the serotonergic system may not be critical for the expression of phasic fear-potentiated startle (Davis et al, 1988).”
From Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety (2010) · cites this paper as Davis et al, 1988
Citations
Cites
Pazos, A., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90856-x · Cited by 1,855 · cited 1×
“Binding studies have indicated that the hippocampus has high densities of 5-HT1A binding sites (Pazos and Palacios 1985).”
BackgroundReconciling the role of central serotonin neurons in human and animal behavior
Soubrié, P. (1986) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00022871 · Cited by 996
Tricklebank, M. D., Forler, C., & Fozard, J. R. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90714-3 · Cited by 675 · cited 1×
“Moreover, exploratory studies showed that pindolol (10 mg/kg), another 5-HT1 antagonist (Tricklebank et al. 1984), also did not prevent buspirone's anxiolytic effect.”
BackgroundAn animal behavior model for studying central serotonergic synapses
Jacobs, B. L. (1976) · Life Sciences · doi:10.1016/0024-3205(76)90303-9 · Cited by 556 · cited 2×
“1986) or only weakly effective (Hjorth and Carlsson 1982) at producing the °'5-HT syndrome" characteristic of 5-HT1A receptor activation (Jacobs 1976).”
BackgroundAfferent projections to the rat locus coeruleus as determined by a retrograde tracing technique
Cedarbaum, J. M., & Aghajanian, G. K. (1978) · Journal of Comparative Neurology · doi:10.1002/cne.901780102 · Cited by 549 · cited 1×
“Second, unlike clonidine, which depresses single unit firing of locus coeruleus neurons (Cedarbaum and Aghajanian 1978), buspirone actually increases locus coeruleus firing through a mechanism independent of ~2-adrenergic receptors (Sanghera and German 1983).”
BackgroundHitchcock, J., & Davis, M. (1986) · Behavioral Neuroscience · doi:10.1037/0735-7044.100.1.11 · Cited by 541
Self-citationThe neurobiology of the nucleus accumbens
Bailey, P. E. (1982) · Neuroscience · doi:10.1016/0306-4522(82)90145-2 · Cited by 451 · cited 1×
“As indicated in the Introduction, buspirone has been reported to bind to dopamine receptors (Stanton et al. 1981; Peroutka 1985).”
Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors
Peroutka, S. J. (1985) · Biological Psychiatry · doi:10.1016/0006-3223(85)90194-5 · Cited by 369 · cited 1×
“Buspirone produces an agonistlike reduction in serotonin turnover in various areas of the rodent brain (Hjorth and Carlsson 1982) and it binds with high affinity to 5-HT1 receptors (Glasser and Traber 1983), probably of the 5-HTIA subtype (Peroutka 1985).”
BackgroundPsychopharmacology: The Third Generation of Progress
ROGERS, K. L. (1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.9.1161 · Cited by 290
Pharmacology and neurochemistry of buspirone.
Riblet, L. A., Taylor, D. P., Eison, M. S., & Stanton, H. C. (1982) · PubMed · Cited by 287
Research works printed but not linked: 4
- Andrade R, Nicoll RA (1985) The novel anxiolytic buspirone elicits a small hyperpolarization and seduces serotonin responses at putative 5-HT1 receptors on hippocampal CA1 pyramidal cells. Soc Neurosci Abstr 11:597
- Lucki I, Ward HR (1986) Antagonism of serotonin-mediated behaviors in rats by pretreatment with the non-benzodiazepine anxiolytics buspirone or ipsapirone. Soc Neurosci Abstr 12:1236
- Mauk MD, Peroutka SJ, Kocsis JD (1985) Modulation of synaptic transmission in the hippocampus produced by novel anxiolytics (Buspirone, TVX-Q & DPAT). Soc Neurosci Abstr 11:135
- Reynolds LS, Seymour PA, Heym J (1986) Inhibition of the behavioral effects of 8-OH-DPAT by the novel anxiolytics buspirone, gepirone and isapirone. Soc Neurosci Abstr 12:481
Cited by
Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety
Davis, M., Walker, D. L., Miles, L., & Grillon, C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.109 · Cited by 1,513
Self-citationFear-potentiated startle: A neural and pharmacological analysis
Davis, M., Falls, W. A., Campeau, S., & Kim, M. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90102-v · Cited by 748
Self-citationGriebel, G. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)98597-j · Cited by 488
DAVIS, M., WALKER, D. L., & LEE, Y. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48289.x · Cited by 281
Self-citationAggression, anxiety and vocalizations in animals: GABAA and 5-HT anxiolytics
Miczek, K. A., Weerts, E. M., Vivian, J. A., & Barros, H. M. (1995) · Psychopharmacology · doi:10.1007/bf02245590 · Cited by 275
Metadata
- Authors
- Davis, M., Cassella, J. V., & Kehne, J. H.
- Affiliations
- Yale University (US)
- ORCID
- Cassella, J. V.
- Venue
- Psychopharmacology
- Published
- 1988
- Volume
- 94
- Issue
- 1
- Pages
- 14-20
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2015340606
- Cited by
- 94
- References
- 44
- Citations by year
- 2023: 1 · 2018: 1 · 2016: 2 · 2015: 1 · 2013: 1 · 2012: 1
- FWCI
- 3.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH 25642, MH 00004)
- National Institute of Neurological Disorders and Stroke (NS-18033)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Keywords
- buspirone, serotonin, 5-HT1A receptor, fear-potentiated startle, anxiolytic effects, dorsal raphe nucleus, median raphe nucleus, cinanserin, cyproheptadine, 8-OH-DPAT, ipsapirone, benzodiazepine receptor, naloxone, yohimbine, p-chlorophenylalanine, p-chloroamphetamine, acoustic startle response
- MeSH terms
- Acoustic Stimulation, Animals, Buspirone, Conditioning, Operant, Fear, Male, Fenclonine, Pyrimidines, Raphe Nuclei, Rats, Inbred Strains, Serotonin, Serotonin Antagonists, Reflex, Startle, Tetrahydronaphthalenes, Anti-Anxiety Agents, 8-Hydroxy-2-(di-n-propylamino)tetralin, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.